Eisler Capital (Uk) Ltd. Amgen Inc Call Options Transaction History

Eisler Capital (Uk) Ltd.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $3.04 Million - $3.7 Million	11,583 Added 38.42%	41,729 $13 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $2.49 Million - $3.01 Million	9,269 Added 44.4%	30,146 $8.57 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $4.13 Million - $4.66 Million	16,163 Added 342.87%	20,877 $6.01 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $331,036 - $410,990	1,514 Added 47.31%	4,714 $1.27 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $685,664 - $810,784	3,200 New	3,200 $710,000

3,054

409M

7.19M

6.26M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Eisler Capital (Uk) Ltd., based on Form 13F filings with the SEC.

Stay updated on Eisler Capital (Uk) Ltd. with notifications on news.